Page last updated: 2024-08-21

isoxazoles and Cytomegalic Inclusion Disease

isoxazoles has been researched along with Cytomegalic Inclusion Disease in 31 studies

Research

Studies (31)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (6.45)	18.2507
2000's	9 (29.03)	29.6817
2010's	20 (64.52)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Agrawal, N; Beltran, D; Echenique, IA; Najafian, N; Ramirez-Ruiz, L	1
Beersma, MF; Boucher, CA; Falkenburg, F; Hoek, RA; Hoogsteden, HC; Jedema, I; Murk, JL; Pas, SD; Schipper, ME; van Bergeijk, H; van den Blink, B; van Hal, PT; Verkaik, NJ	1
Chmura, A; Ciszek, M; Foroncewicz, B; Mucha, K; Pączek, L	1
Hsieh, SC; Lu, CH; Tsai, JH; Wu, MZ; Yu, CL	1
Behr, J; Giessen, C; Jäger, G; Kneidinger, N; Milger, K; Neurohr, C; Nitschko, H; Schramm, R; Striebinger, H; von Wulffen, W	1
Boeckh, M; Murphy, WJ; Peggs, KS	1
Dęborska-Materkowska, D; Durlik, M; Komuda-Leszek, E; Mikołajczyk, N; Miszewska-Szyszkowska, D; Świder, R; Szmidt, J; Wieczorek-Godlewska, R	1
Botelho-Nevers, E; Gagneux-Brunon, A; Laurent, B; Lucht, F; Mariat, C; Michalet, M; Pillet, S	1
Alioto, D; Ferrari Piquero, JM; Gómez Valbuena, I; Serrano Garrote, O	1
Ambrose, T; Butler, A; Carmichael, A; Duncan, S; English, S; Gkrania-Klotsas, E; Louis-Auguste, J; Massey, D; Middleton, S; Russell, N; Rutter, CS; Sharkey, LM; Woodward, JM	1
Asanuma, H; Kono, H; Morita, S; Nakagawa, K; Oya, M; Shinoda, K; Tamaki, S	1
Ariza-Heredia, E; Chemaly, RF; Doan, V; El Chaer, F; Jan, A; Mori, N; Oliver, N; Shah, D; Tayar, J; Tverdek, F; Wang, E	1
Bright, PD; Donati, M; Gompels, M; Johnston, S	1
Snydman, DR	1
Avery, RK; Bolwell, B; Braun, W; Budev, M; Fatica, R; Krishnamurthi, V; Lard, M; Lurain, N; Mawhorter, SD; Mossad, SB; Poggio, E; Shrestha, R; Stephany, B; Waldman, WJ; Yen-Lieberman, B; Young, JB	1
Burst, V; Teschner, S	1
Barbera, RF; Chuluyan, JC; Colombini, AC; Orden, AO	1
Chacko, B; John, GT	1
Carmichael, A; Goldsmith, PM; Husain, MM; Middleton, SJ; Zhang, H	1
Hua-Song, Z; Qi, R; Xiao-Feng, Z	1
Ishiguro, N; Itoh, T; Kikuta, H; Kobayashi, K; Kodaira, J; Ma, X; Yoshioka, M	1
Chandy, S; Jacob, CK; John, GT; Manivannan, J; Peter, S	1
Avery, RK; Bolwell, BJ; Curtis, J; Kalaycio, M; Kohn, D; Long, JR; Longworth, DL; Lurain, N; Mossad, SB; Pohlman, B; Taege, AJ; Waldman, WJ; Williams, JW; Yen-Lieberman, B	1
Chong, AS; Knight, DA; Ma, L; Meister, GT; Shen, J; Waldman, WJ; Williams, JW; Yin, DP; Zeng, H	1
Balakrishnan, N; Chandy, S; Chandy, SJ; Fleming, DH; Jacob, CK; John, GT; Kirubakaran, MG; Krishnamurthy, K; Manivannan, J; Peter, S	1
Chong, AS; Knight, DA; Meister, GT; Shen, J; Waldman, WJ; Williams, JW; Zeng, H	1
John, GT; Sahni, RD; Sudarsanam, TD	1
Abdelhalim, A; Almyroudis, NG; Battiwalla, M; Becker, J; Elefante, A; McCarthy, A; McCarthy, PL; Paplham, P; Segal, BH; Smith, P	1
Avery, RK; Mossad, SB	1
Chong, AS; Knight, DA; Lurain, NS; Miller, DM; Sedmak, DD; Waldman, WJ; Williams, JW	1
Blinder, L; Chong, AS; Knight, DA; Lurain, NS; Miller, DM; Sedmak, DD; Shen, J; Waldman, WJ; Williams, JW	1

Reviews

6 review(s) available for isoxazoles and Cytomegalic Inclusion Disease

Article	Year
Leflunomide as part of the treatment for multidrug-resistant cytomegalovirus disease after lung transplantation: case report and review of the literature. Transplant infectious disease : an official journal of the Transplantation Society, 2013, Volume: 15, Issue:6 Topics: Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Viral; Drug Therapy, Combination; Female; Foscarnet; Ganciclovir; Humans; Immunoglobulins; Isoxazoles; Leflunomide; Lung Transplantation; Middle Aged; Viral Load	2013
Recent advances in cytomegalovirus: an update on pharmacologic and cellular therapies. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2015, Volume: 21, Issue:1 Topics: Acetates; Adoptive Transfer; Animals; Antiviral Agents; Benzimidazoles; Cell- and Tissue-Based Therapy; Clinical Trials, Phase III as Topic; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Hematopoietic Stem Cell Transplantation; Humans; Isoxazoles; Killer Cells, Natural; Leflunomide; Mice; Organophosphonates; Quinazolines; Ribonucleosides; T-Lymphocytes	2015
Successful low-dose leflunomide treatment for ganciclovir-resistant cytomegalovirus infection with high-level antigenemia in a kidney transplant: A case report and literature review. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2016, Volume: 82 Topics: Antiviral Agents; Cytomegalovirus Infections; Drug Resistance, Viral; Female; Ganciclovir; Humans; Isoxazoles; Kidney Transplantation; Leflunomide; Middle Aged; Transplant Recipients; Treatment Outcome	2016
Successful oral treatment of Ganciclovir resistant cytomegalovirus with Maribavir in the context of primary immunodeficiency: First case report and review. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2017, Volume: 87 Topics: Administration, Oral; Antiviral Agents; Benzimidazoles; Blood; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Viral; Ganciclovir; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Middle Aged; Ribonucleosides; Sputum; Time Factors	2017
Leflunomide: a drug with a potential beyond rheumatology. Immunotherapy, 2010, Volume: 2, Issue:5 Topics: Animals; Antirheumatic Agents; Biological Availability; Contraindications; Cytomegalovirus Infections; Dihydroorotate Dehydrogenase; Female; Fetal Development; Humans; Isoxazoles; Leflunomide; Monitoring, Physiologic; Oxidoreductases Acting on CH-CH Group Donors; Pregnancy; Protein-Tyrosine Kinases; Pyrimidines; Teratoma; Transplantation	2010
Leflunomide: a possible alternative for gangciclovir sensitive and resistant cytomegalovirus infections. Postgraduate medical journal, 2006, Volume: 82, Issue:967 Topics: Animals; Antiviral Agents; Clinical Trials as Topic; Cytomegalovirus Infections; Drug Resistance, Viral; Ganciclovir; Humans; Isoxazoles; Leflunomide; Rats	2006

Trials

2 trial(s) available for isoxazoles and Cytomegalic Inclusion Disease

Article	Year
Leflunomide for cytomegalovirus: bench to bedside. Transplant infectious disease : an official journal of the Transplantation Society, 2012, Volume: 14, Issue:2 Topics: Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Humans; Isoxazoles; Leflunomide; Transplantation	2012
A prospective evaluation of leflunomide therapy for cytomegalovirus disease in renal transplant recipients. Transplantation proceedings, 2005, Volume: 37, Issue:10 Topics: Adult; Antiviral Agents; Cytomegalovirus Infections; Female; Humans; Isoxazoles; Kidney Transplantation; Leflunomide; Male; Middle Aged; Postoperative Complications; Prospective Studies; Treatment Outcome	2005

Other Studies

23 other study(ies) available for isoxazoles and Cytomegalic Inclusion Disease

Article	Year
Ganciclovir Dosing Strategies and Development of Cytomegalovirus Resistance in a Kidney Transplant Recipient: A Case Report. Transplantation proceedings, 2017, Volume: 49, Issue:7 Topics: Aged; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Dose-Response Relationship, Drug; Drug Resistance, Viral; Foscarnet; Ganciclovir; Humans; Immunoglobulins; Immunoglobulins, Intravenous; Isoxazoles; Kidney; Kidney Transplantation; Leflunomide; Male; Organophosphonates; Postoperative Complications; Tissue Donors	2017
Leflunomide as a rescue treatment in ganciclovir-resistant cytomegalovirus infection in a seronegative renal transplant recipient--a case report. Annals of transplantation, 2014, Jan-30, Volume: 19 Topics: Antiviral Agents; Cytomegalovirus Infections; Drug Resistance, Viral; Ganciclovir; Graft Rejection; Humans; Immunocompromised Host; Immunoglobulins; Immunoglobulins, Intravenous; Isoxazoles; Kidney Transplantation; Leflunomide; Male; Middle Aged; Salvage Therapy; Treatment Outcome; Viral Load	2014
Can leflunomide play a role in cytomegalovirus disease prophylaxis besides its antirheumatic effects? Antiviral therapy, 2015, Volume: 20, Issue:1 Topics: Adult; Aged; Antirheumatic Agents; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Drug Administration Schedule; Drug Dosage Calculations; Female; Humans; Isoxazoles; Leflunomide; Viral Load	2015
Trip to immunity: resistant cytomegalovirus infection in a lung transplant recipient. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2014, Volume: 28 Topics: Adult; Antiviral Agents; Cytomegalovirus Infections; Drug Resistance, Viral; Female; Foscarnet; Ganciclovir; Humans; Immunoglobulins; Immunoglobulins, Intravenous; Isoxazoles; Leflunomide; Lung Transplantation; Monitoring, Immunologic; Transplant Recipients	2014
Severe cytomegalovirus infection in a second kidney transplant recipient treated with ganciclovir, leflunomide, and immunoglobulins, with complications including seizures, acute HCV infection, drug-induced pancytopenia, diabetes, cholangitis, and multi-or Annals of transplantation, 2015, Mar-27, Volume: 20 Topics: Adult; Antiviral Agents; Cholangitis; Cytomegalovirus Infections; Diabetes Mellitus, Type 2; Fatal Outcome; Female; Ganciclovir; Hepatitis C; Humans; Immunoglobulins, Intravenous; Isoxazoles; Kidney Transplantation; Leflunomide; Multiple Organ Failure; Pancytopenia; Reoperation; Seizures; Transplant Recipients; Viral Load	2015
A case of BK virus nephropathy in a stem cell transplant recipient: a rare or under-recognized cause for Acute Kidney injury. Medecine et maladies infectieuses, 2015, Volume: 45, Issue:8 Topics: Acute Kidney Injury; Anti-Bacterial Agents; BK Virus; Ciprofloxacin; Cord Blood Stem Cell Transplantation; Cytomegalovirus Infections; Graft vs Host Disease; Humans; Immunocompromised Host; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Middle Aged; Myelodysplastic Syndromes; Plasmapheresis; Polyomavirus Infections; Renal Insufficiency, Chronic; Tumor Virus Infections; Viral Load; Viremia; Virus Activation	2015
[Use of leflunomide in a cytomegalovirus infection resistant: a report of a case]. Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, 2016, Jan-01, Volume: 40, Issue:1 Topics: Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Viral; Female; Humans; Isoxazoles; Leflunomide; Off-Label Use; Viral Load; Young Adult	2016
Cytomegalovirus Infection and Rates of Antiviral Resistance Following Intestinal and Multivisceral Transplantation. Transplantation proceedings, 2016, Volume: 48, Issue:2 Topics: Adult; Aged; Antiviral Agents; Cytomegalovirus Infections; Drug Resistance, Viral; Female; Foscarnet; Ganciclovir; Humans; Immunoglobulins; Immunoglobulins, Intravenous; Immunosuppressive Agents; Intestines; Isoxazoles; Leflunomide; Male; Middle Aged; Retrospective Studies; Viremia	2016
Adjuvant and salvage therapy with leflunomide for recalcitrant cytomegalovirus infections in hematopoietic cell transplantation recipients: A case series. Antiviral research, 2016, Volume: 135 Topics: Aged; Antiviral Agents; Chemotherapy, Adjuvant; Cytomegalovirus; Cytomegalovirus Infections; Drug Monitoring; Drug Resistance, Viral; Drug Therapy, Combination; Female; Foscarnet; Ganciclovir; Hematopoietic Stem Cell Transplantation; Humans; Isoxazoles; Leflunomide; Male; Middle Aged; Salvage Therapy; Transplant Recipients; Virus Activation	2016
Leflunomide: a small step forward in meeting the urgent need for treatment of drug-resistant cytomegalovirus infection. Transplantation, 2010, Aug-27, Volume: 90, Issue:4 Topics: Algorithms; Antiviral Agents; Benzimidazoles; Cytomegalovirus Infections; Drug Resistance, Viral; Ganciclovir; Humans; Isoxazoles; Leflunomide; Ribonucleosides; Stem Cell Transplantation; Transplantation Immunology	2010
Utility of leflunomide in the treatment of complex cytomegalovirus syndromes. Transplantation, 2010, Aug-27, Volume: 90, Issue:4 Topics: Antiviral Agents; Cytomegalovirus Infections; Ganciclovir; Heart Transplantation; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lung Transplantation; Off-Label Use; Organ Transplantation; Retrospective Studies; Risk Assessment; Viral Load	2010
Leflunomide use in a cytomegalovirus infection of a patient with dermatomyositis. Rheumatology international, 2012, Volume: 32, Issue:1 Topics: Antirheumatic Agents; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Dermatomyositis; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Isoxazoles; Leflunomide; Methotrexate; Middle Aged; Opportunistic Infections; Treatment Outcome	2012
Case report: Multidrug-resistant cytomegalovirus in a modified multivisceral transplant recipient. Transplantation, 2012, Apr-15, Volume: 93, Issue:7 Topics: Adult; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Drug Resistance, Multiple, Viral; Female; Foscarnet; Ganciclovir; Humans; Immunosuppressive Agents; Intestine, Small; Isoxazoles; Kidney Transplantation; Leflunomide; Organophosphonates; Pancreas Transplantation; Recurrence; Stomach; Treatment Outcome	2012
Leflunomide inhibits the apoptosis of human embryonic lung fibroblasts infected by human cytomegalovirus. European journal of medical research, 2013, Feb-01, Volume: 18 Topics: Apoptosis; Cell Proliferation; Cell Shape; Cytomegalovirus; Cytomegalovirus Infections; Embryo, Mammalian; Fibroblasts; Humans; Isoxazoles; Leflunomide; Lung; Time Factors	2013
Protein-losing cytomegalovirus gastritis in a patient with Stevens-Johnson syndrome. Digestion, 2002, Volume: 65, Issue:4 Topics: Adolescent; Anticonvulsants; Cytomegalovirus Infections; Female; Gastritis; Gastroscopy; Humans; Immunocompetence; Isoxazoles; Protein-Losing Enteropathies; Stevens-Johnson Syndrome; Zonisamide	2002
Leflunomide therapy for cytomegalovirus disease in renal allograft recepients. Transplantation, 2004, May-15, Volume: 77, Issue:9 Topics: Adult; Antiviral Agents; Cytomegalovirus Infections; Drug Costs; Female; Humans; India; Isoxazoles; Kidney Transplantation; Leflunomide; Male; Middle Aged; Transplantation, Homologous	2004
Use of leflunomide in an allogeneic bone marrow transplant recipient with refractory cytomegalovirus infection. Bone marrow transplantation, 2004, Volume: 34, Issue:12 Topics: Bone Marrow Transplantation; Cytomegalovirus Infections; Drug Resistance, Viral; Drug Therapy, Combination; Fatal Outcome; Female; Foscarnet; Graft vs Host Disease; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Liver Failure; Middle Aged; Salvage Therapy; Transplantation, Homologous; Viral Load	2004
Mechanistic study of malononitrileamide FK778 in cardiac transplantation and CMV infection in rats. Transplantation, 2005, Jan-15, Volume: 79, Issue:1 Topics: Alkynes; Animals; Antiviral Agents; Body Weight; Cytomegalovirus Infections; Graft Rejection; Heart Transplantation; Immunosuppressive Agents; Isoxazoles; Nitriles; Rats; Rats, Inbred BN; Transplantation, Homologous; Uridine; Virus Replication	2005
Concurrent antiviral and immunosuppressive activities of leflunomide in vivo. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2006, Volume: 6, Issue:1 Topics: Animals; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Graft Rejection; Heart; Heart Transplantation; Immunosuppressive Agents; Isoxazoles; Lectins, C-Type; Leflunomide; Lung; Rats; Rats, Inbred Lew; Salivary Glands; Spleen; Transplants; Uridine; Viral Proteins	2006
Leflunomide failure to control recurrent cytomegalovirus infection in the setting of renal failure after allogeneic stem cell transplantation. Transplant infectious disease : an official journal of the Transplantation Society, 2007, Volume: 9, Issue:1 Topics: Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Drug Therapy, Combination; Encephalitis, Viral; Fatal Outcome; Ganciclovir; Hodgkin Disease; Humans; Isoxazoles; Leflunomide; Male; Middle Aged; Organophosphonates; Peripheral Blood Stem Cell Transplantation; Postoperative Complications; Renal Insufficiency; Secondary Prevention; Treatment Failure; Virus Activation	2007
Second look at leflunomide "failure" to control cytomegalovirus infection in the setting of renal failure. Transplant infectious disease : an official journal of the Transplantation Society, 2007, Volume: 9, Issue:3 Topics: Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Humans; Isoxazoles; Leflunomide; Renal Insufficiency	2007
Novel mechanism of inhibition of cytomegalovirus by the experimental immunosuppressive agent leflunomide. Transplantation, 1999, Sep-27, Volume: 68, Issue:6 Topics: Antiviral Agents; Blotting, Northern; Cytomegalovirus; Cytomegalovirus Infections; DNA-Directed DNA Polymerase; DNA, Viral; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Endothelium, Vascular; Fibroblasts; Foscarnet; Gene Expression; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Time Factors; Transcription, Genetic; Umbilical Veins; Viral Proteins; Virus Replication	1999
Inhibition of cytomegalovirus in vitro and in vivo by the experimental immunosuppressive agent leflunomide. Intervirology, 1999, Volume: 42, Issue:5-6 Topics: Animals; Antiviral Agents; Cells, Cultured; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Drug Resistance, Microbial; Drug Resistance, Multiple; Endothelium, Vascular; Fibroblasts; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Rats; Uridine	1999